HCRT and non-functioning pituitary adenoma: Considering the comparison between controls and each neurocognitive disorder group, CSF orexin-A levels were significantly higher in patients with NFPA (p < 0.001), iNPH (p < 0.001), and msAD (p < 0.001) than in controls (Table 2).